Stay updated on BMN 111 in Achondroplasia: Pediatric Clinical Trial
Sign up to get notified when there's something new on the BMN 111 in Achondroplasia: Pediatric Clinical Trial page.

Latest updates to the BMN 111 in Achondroplasia: Pediatric Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has been updated to include a government-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference1%

- Check27 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.2%

- Check41 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; 'Back to Top' was removed. Overall, this is a minor update with no changes to core content, pricing, stock, or time-sensitive information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe web page has been updated to include new facility and drug information, specifically regarding Vosoritide and its related publications, while removing some location details and previous genetic resources.SummaryDifference4%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to BMN 111 in Achondroplasia: Pediatric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 111 in Achondroplasia: Pediatric Clinical Trial page.